The weekly litigation news digest is live. Subscribe now

IP Verse

Tablet Including 7-[4-(4-Benzo[Beta]Thiophen-4-Yl-Piperazin-1-Yl) Butoxy]-1H-Quinolin-2-One Or Salt Thereof - EP2767285

The patent EP2767285 was granted to Otsuka Pharmaceutical on Feb 19, 2025. The application was filed on Oct 12, 2012 under application number EP12840025A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2767285

OTSUKA PHARMACEUTICAL
Application Number
EP12840025A
Filing Date
Oct 12, 2012
Status
Patent Maintained As Amended
Jan 17, 2025
Publication Date
Feb 19, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
TEVA PHARMACEUTICALSAug 12, 2020ELKINGTON AND FIFEADMISSIBLE
MAIWALDAug 11, 2020MAIWALDADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONJP2006316052
EXAMINATIONUS2009318560
EXAMINATIONUS2010105710
INTERNATIONAL-SEARCH-REPORTJP2006316052
INTERNATIONAL-SEARCH-REPORTJP2008115172
OPPOSITIONEP2359816
OPPOSITIONUS2009318560
OPPOSITIONUS2010105710
OPPOSITIONUS2011152286
OPPOSITIONWO2006097344
OPPOSITIONWO2006112464
OPPOSITIONWO2012137971
SEARCHUS2011152286
SEARCHWO2012137971

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents